Juvenile Idiopathic Arthritis Associated Uveitis. Current Status: Epidemiology, Pathogenesis, and Clinical Issues

QR Code

Juvenile Idiopathic Arthritis Associated Uveitis. Current Status: Epidemiology, Pathogenesis, and Clinical Issues

Uveitis is the most common extraarticular manifestation of juvenile idiopathic arthritis (JIA) and with no adequate management results in serious eye complications such as cataracts, secondary glaucoma, retinal detachment, and linear corneal dystrophy. This pathology reduces patients’ quality of lif...

Full description

Saved in:

Bibliographic Details
Main Authors:	Alexandr A. Yakovlev, Tatiana N. Nikitina, Mikhail M. Kostik
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2024-12-01
Series:	Вопросы современной педиатрии
Subjects:	uveitis juvenile idiopathic arthritis iridocyclitis panuveitis antinuclear antibody hla b27 antigen
Online Access:	https://vsp.spr-journal.ru/jour/article/view/3651
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Juvenile Idiopathic Arthritis Associated Uveitis. Modern Therapy Approaches: Narrative Review
by: Alexandr A. Yakovlev, et al.
Published: (2025-07-01)

HLA-B27-associated uveitis: an independent disease or a variant of spondyloarthritis?
by: A. A. Godzenko, et al.
Published: (2020-09-01)

The Efficiency of Adalimumab in Cases of Chronic Methotrexate-Resistant Juvenile Idiopathic Arthritis-Associated Anterior Uveitis: Retrospective Case Series Study
by: E. V. Gaidar, et al.
Published: (2016-11-01)

Efficacy of Abatacept Therapy in a Patient with Juvenile Idiopathic Arthritis and Bilateral Uveitis
by: Lelia A. Galstian, et al.
Published: (2016-08-01)

Differentiated Approach to the Surgical Treatment of Chronic Uveitis in Juvenile Idiopathic Arthritis
by: A. V. Tereshchenko, et al.
Published: (2018-07-01)

Can the Methotrexate Therapy Prevent the Development of Uveitis in Patients with Juvenile Idiopathic Arthritis: Results of a Retrospective Study
by: M. M. Kostik, et al.
Published: (2015-09-01)

EXPERIENCE OF THE ADALIMUMAB APPLICATION FOR THE PATIENT WITH EARLY DEBUT OF JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
by: K. B. Isaeva, et al.
Published: (2014-07-01)

HLA-B27-associated uveitis: From pathogenesis to therapy
by: A. B. Demina, et al.
Published: (2016-01-01)

TREATMENT APPROACH FOR JUVENILE IDIOPATHIC ARTHRITIS-RELATED UVEITIS: 2012 UPDATE
by: Francesco Zulian, et al.
Published: (2012-09-01)

EFFICACY OF USE OF TNF INHIBITOR ADALIMUMAB IN A FEMALE PATIENT WITH CHRONIC UVEITIS IN THE ONSET OF JUVENILE IDIOPATHIC ARTHRITIS
by: T. V. Pavkhun, et al.
Published: (2016-02-01)

ADALIMUMAB USAGE CASE IN A PATIENT WITH JUVENILE OLIGOARTHRITIS AND UVEITIS
by: L. A. Balykova, et al.
Published: (2013-11-01)

EFFICACY AND SAFETY OF PEDIATRIC JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS TREATMENT WITH ADALIMUMAB
by: E. I. Alexeeva, et al.
Published: (2012-01-01)

EFFECTIVE USE OF MONOCLONAL ANTIBODIES AGAINST TNF — ADALIMUMAB — AS A SWITCHOVER DRUG IN A PATIENT WITH JUVENILE IDIOPATHIC POLYARTHRITIS AND UVEITIS
by: S. A. Ushakova, et al.
Published: (2014-11-01)

EXPERIENCE WITH ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS
by: Margarita Fedorovna Dubko, et al.
Published: (2012-10-01)

Adherence to screening recommendations for uveitis in juvenile idiopathic arthritis (JIA) patients: A retrospective cohort study from a tertiary referral hospital in Oman
by: Fatma Al Hosni, et al.
Published: (2025-05-01)

Experience of Parenteral Administration of Methotrexate in a Female Patient Suffering from Early Juvenile Idiopathic Arthritis and Uveitis
by: Т. V. Sleptsova, et al.
Published: (2015-08-01)

Etiology and Anatomical Location of Uveitis—Prognostic Factors for Disease Course and Laterality
by: Vesela Todorova Mitkova-Hristova, et al.
Published: (2025-05-01)

EFFICACY OF ADALIMUMAB IN A PATIENT WITH JUVENILE IDIOPATHIC ARTHRITIS AND UVEITIS
by: L. A. Galstyan, et al.
Published: (2012-11-01)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF TREATMENT USING ADALIMUMAB IN COMBINATION WITH METHOTREXATE AND METHOTREXATE MONOTHERAPY IN CHILDREN WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS IN COMBINATION WITH UVEITIS
by: V. А. Kel’tsev, et al.
Published: (2014-12-01)

The Experience of Successful Use of Adalimumab in a Patient With Juvenile Arthritis Associated With Enthesitis and Uveitis
by: Aleksandra M. Chomakhidze, et al.
Published: (2017-10-01)

Relationship of genetic polymorphism of the acute phase marker of inflammation rs12218 of the SAA1 gene with clinical phenotypes of juvenile idiopathic arthritis
by: M. Yu. Krylov, et al.
Published: (2021-04-01)

TH-17 PHENOTYPE OF JUVENILE IDIOPATHIC ARTHRITIS
by: I. Z. Turtsevich1, et al.
Published: (2015-08-01)

Histocompatibility HLA class I in anterior uveitis patients with and without spondyloarthritis
by: I. A. Guseva, et al.
Published: (2018-04-01)

<i>STAT4</i> rs7574865 G/T and <i>IRF5</i> rs2004640 G/T polymorphisms as markers of predisposition to juvenile idiopathic arthritis. What can genetics give to understand its heterogeneity?
by: E. S. Fedorov, et al.
Published: (2019-10-01)

Efficacy of genetically engineered biological agents in the treatment of uveitis associated with rheumatic diseases in children
by: V V Neroyev, et al.
Published: (2012-08-01)

Safety of antibodies to measles, mumps, rubella and diphtheria in patients with juvenile idiopathic arthritis
by: I. V. Fridman, et al.
Published: (2021-07-01)

Role of vitamin D receptor (VDR) gene polymorphism in the pathogenesis of juvenile idiopathic arthritis: Theoretical and practical aspects
by: M. M. Kostik, et al.
Published: (2014-09-01)

RESULTS OF RETROSPECTIVE OBSERVATIONAL STUDY OF ADALIMUMAB SAFETY AND EFFICACY IN PATIENTS WITH JUVENILE ARTHRITIS AND UVEITIS
by: Е.I. Alexeeva, et al.
Published: (2011-11-01)

Experience of the Successful Treatment With Canakinumab of a Patient With Systemic Juvenile Idiopathic Arthritis
by: Ekaterina I. Alexeeva, et al.
Published: (2017-06-01)

Differences of hip involvement in systemic and non-systemic juvenile idiopathic arthritis
by: L. S. Sorokina, et al.
Published: (2022-03-01)

Efficacy and Safety of Immunization With Pneumococcal Polysaccharide Vaccine in Children With Juvenile Idiopathic Arthritis: Preliminary Results of a Prospective Open-Label Study
by: Ekaterina I. Alexeeva, et al.
Published: (2017-06-01)

A HISTORY CASE OF ADALIMUMAB TREATMENT IN A FEMALE PATIENT WITH JUVENILE ARTHRITIS AND UVEITIS AS MANIFESTATIONS OF CROHN’S DISEASE
by: V. A. Malievskii, et al.
Published: (2013-07-01)

Review of International Registers of Patients with Systemic Juvenile Idiopathic Arthritis
by: Ekaterina I. Alekseeva, et al.
Published: (2017-04-01)

Effectiveness and Safety of Vaccination in Patients with Juvenile Idiopathic Arthritis
by: Irina V. Fridman, et al.
Published: (2021-12-01)

ADALIMUMAB IN TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
by: R. V. Denisova, et al.
Published: (2013-12-01)

Causes of invalidity in patients with juvenile idiopathic arthritis
by: T A Slielepina
Published: (2005-04-01)

Methotrexate in the combination therapy of juvenile idiopathic arthritis
by: E. S. Zholobova, et al.
Published: (2018-09-01)

Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case
by: E. I. Alekseeva, et al.
Published: (2016-11-01)

Current approaches to treatment of uveitis in immune-mediated inflammatory rheumatic disease
by: T. A. Lisitsyna, et al.
Published: (2020-09-01)

Can remission be in juvenile idiopathic arthritis without the use of biological agents?
by: S. I. Valieva, et al.
Published: (2019-09-01)